P. Jungers

发表

Recurrence rates of urinary calculi according to stone composition and morphology

M. Daudon, P. Jungers, Dominique Bazin, 2018, Urolithiasis.

Iconography : Comprehensive morpho-constitutional analysis of urinary stones improves etiological diagnosis and therapeutic strategy of nephrolithiasis

M. Daudon, P. Jungers, A. Dessombz, 2016 .

Liver changes and complications in adult polycystic kidney disease.

P. Jungers, D. Droz, J. Grünfeld, 1985, Advances in nephrology from the Necker Hospital.

[Urinary stones and urinary tract abnormalities. Is the stone composition independent of the anatomical abnormality?].

M. Daudon, P. Jungers, F. Cohen-Solal, 2003, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Immunological considerations of the uremic and dialyzed patient.

P. Jungers, L. Chatenoud, B. Descamps-Latscha, 1994, Kidney international. Supplement.

Immune system dysregulation in uremia.

P. Jungers, L. Chatenoud, B. Descamps-Latscha, 1994, Seminars in nephrology.

Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes.

P. Jungers, A. Moynot, P. Roux‐Lombard, 1995, Journal of immunology.

Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure.

P. Jungers, B. Descamps-Latscha, J. Zingraff, 1996, Free radical biology & medicine.

Urinary calculi: review of classification methods and correlations with etiology.

M Daudon, M. Daudon, P. Jungers, 1993, Scanning microscopy.

Advanced oxidation protein products as a novel marker of oxidative stress in uremia.

P. Jungers, B. Descamps-Latscha, J. Zingraff, 1996, Kidney international.

The Essentials in Hemodialysis

P. Jungers, J. Zingraff, N. Man, 1978, The Tardieu Series.

Dyslipidaemia and the progression of renal disease in chronic renal failure patients.

Z. Massy, P. Jungers, B. Lacour, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Diffraction techniques and vibrational spectroscopy opportunities to characterise bones

M. Daudon, P. Jungers, D. Bazin, 2009, Osteoporosis International.

Osmotic Nephrosis Induced by Water-Soluble Triiodinated Contrast Media in Man. A Retrospective Study of 47 Cases.

P. Jungers, D. Droz, D. Kleinknecht, 1975, Radiology.

Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate.

M. Dougados, P. Jungers, J. Bach, 1985, Arthritis and rheumatism.

Validation of Surrogates of Urine Osmolality in Population Studies

C. Hayward, O. Polašek, M. Bochud, 2017, American Journal of Nephrology.

Urinary stones in HIV-1-positive patients treated with indinavir

M. Daudon, P. Jungers, D. Joly, 1997, The Lancet.

Viral Infections in Dialysis Patients Part B: Dialysis Associated Hepatitis

P. Jungers, F. Degos, 1996 .

Dialysis Associated Hepatitis

P. Jungers, F. Degos, J. Crosnier, 1989 .

Incidence of anaemia, and use of epoetin therapy in pre-dialysis patients: a prospective study in 403 patients.

Z. Massy, P. Jungers, G. Choukroun, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers.

G. London, A. Guérin, P. Jungers, 2004, Kidney international.

Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes.

P. Jungers, J. Grünfeld, D. Joly, 2003, Journal of the American Society of Nephrology : JASN.

Comparison of ketoacids and low protein diet on advanced chronic renal failure progression.

P. Jungers, P. Chauveau, N. Man, 1987, Kidney international. Supplement.

Medical treatment of cystinuria: critical reappraisal of long-term results.

P. Rieu, M. Daudon, P. Jungers, 2000, The Journal of urology.

Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.

P. Jungers, O. Meyer, O. Blétry, 1987, The Journal of rheumatology.

Late referral to maintenance dialysis: detrimental consequences.

P. Jungers, G. Albouze, P. Chauveau, 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[Continued late referral of patients with chronic kidney disease. Causes, consequences, and approaches to improvement].

P. Jungers, J. Grünfeld, D. Joly, 2008, Presse medicale.

Late referral: loss of chance for the patient, loss of money for society.

P. Jungers, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Screening for renal insufficiency: is it worth while? is it feasible?

P. Jungers, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

HLA antigen in three types of glomerulonephritis.

J. Dausset, P. Jungers, J. Bach, 1978, Clinical immunology and immunopathology.

Effect of moderate protein restriction on the rate of progression of chronic renal failure.

P. Jungers, G. Albouze, P. Chauveau, 1989, Kidney international. Supplement.

Factors affecting progression in advanced chronic renal failure.

P. Jungers, G. Albouze, B. Lacour, 1993, Clinical nephrology.

Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors.

P. Jungers, G. Albouze, B. Descamps-Latscha, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Increased plasma homocysteine concentration in patients with chronic renal failure.

P. Jungers, P. Chauveau, P. Kamoun, 1992, Mineral and electrolyte metabolism.

Low-protein diet and chronic renal failure

N. Gretz, F. Locatelli, P. Jungers, 1991, The Lancet.

Nephrology Dialysis Transplantation Genetic kidney diseases in the elderly

S. Richard, P. Jungers, J. Grünfeld, 1998 .

Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients.

Z. Massy, P. Jungers, D. Joly, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Immunological and Chronic Inflammatory Abnormalities in End Stage Renal Disease

P. Jungers, B. Descamps-Latscha, 1996 .

The rate of progression of renal failure in ADPKD.

P. Jungers, G. Choukroun, J. Grünfeld, 1995, Contributions to nephrology.

Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.

P. Jungers, G. Albouze, A. Moynot, 1998, Kidney international.

Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients.

P. Jungers, P. Chauveau, P. Kamoun, 1993, Kidney international. Supplement.

Specific controversies concerning the natural history of renal disease in pregnancy.

P. Houillier, P. Jungers, M. Henry-Amar, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pregnancy in IgA nephropathy, reflux nephropathy, and focal glomerular sclerosis.

P. Houillier, P. Jungers, J. Grünfeld, 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients.

M. Dougados, P. Jungers, J. Bach, 1982, Archives of internal medicine.

Detrimental effects of late referral in patients with chronic renal failure: a case-control study.

P. Jungers, G. Albouze, J. Zingraff, 1993, Kidney international. Supplement.

Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA.

P. Jungers, R. Monteiro, J. Bach, 1998, Kidney international.

Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure.

P. Jungers, P. Kamoun, P. Chauveau, 1996, Mineral and electrolyte metabolism.

Pregnancy in lupus nephritis and related disorders.

P. Houillier, P. Jungers, J. Grünfeld, 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy.

Z. Massy, P. Jungers, B. Chadefaux-Vekemans, 1999, Kidney international.

Uremic cardiomyopathy and pericarditis.

P. Jungers, J. Zingraff, T. Drüeke, 1980, Advances in nephrology from the Necker Hospital.

Anemia and secondary hyperparathyroidism.

P. Jungers, J. Zingraff, T. Drüeke, 1978, Archives of internal medicine.

Early alterations of plasma free amino acids in chronic renal failure.

P. Jungers, P. Parvy, P. Kamoun, 1990, Clinica chimica acta; international journal of clinical chemistry.

PRACTICAL PEDIA T RIC NEPHROLOGY

P. Rieu, M. Daudon, P. Jungers, 1999 .

Soluble CD23 as an effector of immune dysregulation in chronic uremia and dialysis.

P. Jungers, D. de Groote, P. Chauveau, 1993, Kidney international.

Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients.

Z. Massy, P. Jungers, B. Descamps-Latscha, 2001, Kidney international. Supplement.

Treatment of cystinuria

P. Rieu, M. Daudon, P. Jungers, 1999, Pediatric Nephrology.

Immune System Dysregulation in Uremia: Role of Oxidative Stress

P. Jungers, B. Descamps-Latscha, V. Witko-Sarsat, 2002, Blood Purification.

Heavy elements in urinary stones

M. Daudon, P. Jungers, D. Bazin, 2007, Urological Research.

Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus.

G. Hughes, P. Jungers, M. Khamashta, 1993, The Journal of rheumatology.

[Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].

M. Daudon, P. Jungers, B. Knebelmann, 2008, Nephrologie & therapeutique.

TIMING OF HEPATITIS B REVACCINATION IN HEALTHY ADULTS

P. Jungers, A. Laplanche, E. Benhamou, 1987, The Lancet.

Hepatitis B vaccine in dialysis patients.

P. Jungers, A. Laplanche, E. Benhamou, 1984, The New England journal of medicine.

RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: I, MEDICAL STAFF

P. Jungers, B. Lacour, A. Laplanche, 1981, The Lancet.

Pregnancy and end-stage renal disease--past experience and new insights.

P. Jungers, I. Giatras, D. Levy, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Tubular Nephrotoxicity of Water‐soluble Iodinated Contrast Media

P. Jungers, D. Droz, L. Noel, 1980, Investigative radiology.

Hepatitis B antigen-associated periarteritis nodosa in patients undergoing long-term hemodialysis.

G. Feldmann, P. Jungers, J. Bach, 1980, The American journal of medicine.

Low plasma androgens in women with active or quiescent systemic lupus erythematosus.

M. Dougados, P. Jungers, J. Bach, 1982, Arthritis and rheumatism.

[Plasma androgens in women with systemic lupus erythematosus].

P. Jungers, J. Bach, K. Nahoul, 1980, Pathologie-biologie.

Advanced oxidation protein products: oxidative stress markers and mediators of inflammation in uremia.

P. Jungers, B. Descamps-Latscha, T. Drüeke, 1998, Advances in nephrology from the Necker Hospital.

A circulating inhibitor of the RBC membrane calcium pump in chronic renal failure.

P. Jungers, J. Zingraff, T. Drüeke, 1992, Kidney international.

Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.

P. Jungers, B. Bauvois, T. Nguyen-Khoa, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Drug‐Induced Stones

M. Daudon, P. Jungers, 2014 .

HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?

P. Jungers, A. Laplanche, E. Benhamou, 1984, The Lancet.

[Efficacy of a French hepatitis B vaccine. Results of a multicenter clinical trial, using a placebo, with double-blind randomized administration].

P. Jungers, B. Lacour, A. Laplanche, 1980, Bulletin de l'Academie nationale de medecine.

The effect of 1α(OH)D3 and 1α,25(OH)2D3 on the bone in patients with renal osteodystrophy

H. Rasmussen, P. Jungers, P. Marie, 1978 .

Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients.

P. Jungers, P. Kamoun, P. Chauveau, 1997, Mineral and electrolyte metabolism.

Calciuric response to an acute acid load in healthy subjects and hypercalciuric calcium stone formers.

P. Houillier, P. Jungers, M. Froissart, 1996, Kidney international.

Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia.

P. Jungers, B. Descamps-Latscha, T. Drüeke, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Serial crystalluria determination and the risk of recurrence in calcium stone formers.

M. Daudon, P. Jungers, B. Lacour, 2005, Kidney international.

The advanced glycation endproduct pentosidine and monocyte activation in uremia.

P. Jungers, C. Verger, V. Witko-Sarsat, 1996, Clinical nephrology.

Is the process of urinary urea concentration responsible for a high glomerular filtration rate?

P. Jungers, L. Bankir, B. Lacour, 1993, Journal of the American Society of Nephrology : JASN.

Cystine crystal volume determination: a useful tool in the management of cystinuric patients

M. Daudon, P. Jungers, B. Knebelmann, 2003, Urological Research.

Elements of applied immunology for the intensive care unit and chronic uremia-related disorders

P. Jungers, B. Descamps-Latscha, 1998 .

Hepatitis B vaccine: randomized trial of immunogenicity in hemodialysis patients.

P. Jungers, A. Laplanche, F. Degos, 1984, Clinical nephrology.

RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: II, HAEMODIALYSIS PATIENTS

P. Jungers, B. Lacour, A. Laplanche, 1981, The Lancet.

HLA genetic heterogeneity of hepatitis B vaccine response in hemodialyzed patients.

P. Jungers, G. Albouze, J. Bach, 1993, Kidney international. Supplement.

Pituitary and ovarian dysfunctions in women on haemodialysis.

P. Jungers, J. Zingraff, M. Feinstein, 1982, Nephron.

New molecular aspects of chronic uraemia and dialysis-related immunocompetent cell activation.

P. Jungers, B. Descamps-Latscha, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Drug-Induced Renal Stones

M. Daudon, P. Jungers, 2010 .

Detection of Hepatitis B Antigen in Circulating Immune Complexes in Acute and Chronic Hepatitis

G. Feldmann, P. Jungers, J. Bach, 1977, Scandinavian journal of immunology.

[Determination of extracellular fluid volume in humans by measurement of total body impedance].

P. Jungers, A. Thomasset, J. Lenoir, 1970, La Presse medicale.

[Determination of extracellular and intracellular liquid volumes of the human body by electric measurement].

P. Jungers, A. Thomasset, P. Jenin, 1969, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles.

Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment

M. Daudon, P. Jungers, Dominique Bazin, 2018, Drugs.

The pathogenesis of Randall's plaque: a papilla cartography of Ca compounds through an ex vivo investigation based on XANES spectroscopy.

M. Daudon, P. Jungers, Dominique Bazin, 2010, Journal of synchrotron radiation.

Respective influence of calcium and oxalate urine concentration on the formation of calcium oxalate monohydrate or dihydrate crystals

M. Daudon, P. Jungers, V. Frochot, 2016 .

Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach

M. Daudon, P. Jungers, B. Lacour, 2004, Urological Research.

Stone Composition and Morphology: A Window on Etiology

M. Daudon, P. Jungers, 2012 .

Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology.

M. Daudon, O. Traxer, P. Jungers, 2009, Urology.

Urolithiasis in patients with end stage renal failure.

M. Daudon, P. Jungers, B. Lacour, 1992, The Journal of urology.

Piridoxilate-induced calcium oxalate calculi: a new drug-induced metabolic nephrolithiasis.

M. Daudon, P. Jungers, M. Normand, 1987, The Journal of urology.

High prevalence of uric acid calculi in diabetic stone formers.

M. Daudon, P. Jungers, B. Lacour, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical Value of Crystalluria and Quantitative Morphoconstitutional Analysis of Urinary Calculi

M. Daudon, P. Jungers, 2004, Nephron Physiology.

Peculiar morphology of stones in primary hyperoxaluria.

M. Daudon, P. Jungers, Dominique Bazin, 2008, The New England journal of medicine.

Unusual morphology of calcium oxalate calculi in primary hyperoxaluria.

M. Daudon, P. Jungers, B. Lacour, 1998, JN. Journal of Nephrology (Milano. 1992).

Stone formation and pregnancy: pathophysiological insights gained from morphoconstitutional stone analysis.

M. Daudon, P. Meria, P. Jungers, 2010, The Journal of urology.

Revisiting the localisation of Zn(2+) cations sorbed on pathological apatite calcifications made through X-ray absorption spectroscopy.

M. Daudon, P. Jungers, Dominique Bazin, 2009, Biochimie.

[Analytical methods of calculi and urinary crystals].

M. Daudon, P. Jungers, 1991, La Revue du praticien.

ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention.

M. Daudon, P. Jungers, G. Choukroun, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Combined Influence of Urinary Calcium and Oxalate Concentrations on Crystal Formation in Stone Formers

M. Daudon, P. Jungers, R. Reveillaud, 1989 .

Drug-Induced Renal Calculi

M. Daudon, P. Jungers, 2006, Drugs.

Methodological aspects of spontaneous crystalluria studies in calcium stone formers.

M. Daudon, P. Jungers, C. Bader, 1994, Scanning microscopy.

Inhibitors of crystallization.

M. Daudon, P. Jungers, B. Lacour, 1995, Advances in nephrology from the Necker Hospital.

Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers

M. Daudon, P. Jungers, B. Lacour, 2004, Urological Research.

Crystalluria analysis improves significantly etiologic diagnosis and therapeutic monitoring of nephrolithiasis

M. Daudon, P. Jungers, V. Frochot, 2016 .

Encrusted pyelitis: an underdiagnosed condition?

P. Meria, P. Jungers, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Type 2 diabetes increases the risk for uric acid stones.

M. Daudon, O. Traxer, P. Jungers, 2006, Journal of the American Society of Nephrology : JASN.

Very first tests on SOLEIL regarding the Zn environment in pathological calcifications made of apatite determined by X-ray absorption spectroscopy.

M. Daudon, O. Traxer, P. Jungers, 2008, Journal of synchrotron radiation.

Diabetes and nephrolithiasis

M. Daudon, P. Jungers, 2007, Current diabetes reports.

[Clinical value of crystalluria study].

M. Daudon, P. Jungers, B. Lacour, 2004, Annales de biologie clinique.

Stones in primary hyperoxaluria--a clarification.

M. Daudon, P. Jungers, Dominique Bazin, 2009, The New England journal of medicine.

Influence of body size on urinary stone composition in men and women

M. Daudon, P. Jungers, B. Lacour, 2006, Urological Research.

[Encrusted pyelitis: early diagnosis facilitates conservative management].

P. Meria, P. Jungers, 2008, Presse medicale.

Encrusted pyelitis of native kidneys.

P. Rieu, P. Jungers, Y. Chrétien, 2000, Journal of the American Society of Nephrology : JASN.

Pregnancy in renal disease.

P. Jungers, D. Chauveau, Dominique Chauveau, 1997, Kidney international.

Stone Morphology: Implication for Pathogenesis

M. Daudon, P. Jungers, D. Bazin, 2008 .

Stone Morphology Suggestive of Randall’s Plaque

M. Daudon, O. Traxer, P. Jungers, 2007 .

Epidemiology, Prevention and Management

M. Daudon, P. Jungers, 2004 .

Anti-glomerular-basement-membrane disease after lithotripsy

F. Lallemand, P. Jungers, D. Droz, 1990, The Lancet.

Relationship between liver histopathological changes and HBsAg in 111 patients treated by long-term hemodialysis.

C. Degott, P. Jungers, F. Degos, 2008, Liver.

HL-A 1,8 PHENOTYPE AND HBS ANTIGENÆMIA IN HÆMODIALYSIS PATIENTS

P. Jungers, J. Zingraff, J. Bach, 1975, The Lancet.

Drug-induced renal calculi: epidemiology, prevention and management.

M. Daudon, P. Jungers, 2004, Drugs.

Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure.

P. Jungers, J. Dayer, J. Dayer, 1998, Journal of immunology.

Uremic and non-uremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis.

P. Jungers, J. Chanard, D. Kleinknecht, 1972, Kidney international.

Inefficacy and toxicity of pefloxacin in focal and segmental glomerulosclerosis with steroid-resistant nephrotic syndrome

P. Jungers, D. Chauveau, J. Grünfeld, 1993, The Lancet.

11 Reflux nephropathy and pregnancy

P. Jungers, 1987 .

Factors influencing immediate prognosis in acute renal failure, with special reference to prophylactic hemodialysis.

P. Jungers, J. Chanard, D. Kleinknecht, 1971, Advances in nephrology from the Necker Hospital.

Advanced Oxidation Protein Products as Novel Mediators of Inflammation and Monocyte Activation in Chronic Renal Failure1, 2

P. Jungers, J. Dayer, B. Descamps-Latscha, 1998, The Journal of Immunology.

[Nephrotoxicity of cephaloridine. 3 cases of acute renal failure with anuria].

J. Watchi, P. Loirat, P. Jungers, 1969, La Presse medicale.

Nephrotoxicity of Cephaloridine

P. Jungers, J. Fillastre, D. Kleinknecht, 1974 .

Investigations on clinico-chemical correlations in uraemic polyneuritis.

P. Jungers, J. Zingraff, N. Man, 1975, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Perimacular changes in Alport's syndrome.

P. Jungers, J. Grünfeld, L. Noël, 1980, Clinical nephrology.

Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.

J. Barré, G. Houin, P. Jungers, 1986, Clinical nephrology.

INVESTIGATION OF PHAGOCYTE OXIDATIVE METABOLISM IN MICROAMOUNTS OF WHOLE BLOOD FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

M. Dougados, A. Baruchel, R. Golub, 1984 .

Recurrent hematuria in 4 white patients with sickle cell trait.

É. Oksenhendler, P. Jungers, D. Droz, 1984, The Journal of urology.

Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease.

B. Balkau, O. Lantieri, M. Marre, 2014, The Journal of clinical endocrinology and metabolism.

[Complications of osmotic nephrosis after perfusion urography in renal insufficiency].

P. Jungers, D. Kleinknecht, N. Hinglais, 1971, Annales de medecine interne.

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients.

P. Jungers, G. Choukroun, A. Nguyen, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Long-Term Hemodialysis

N. K. Man, P. Jungers, J. Zingraff, 1995, Springer Netherlands.

Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure.

P. Jungers, G. Albouze, B. Lacour, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Tolerance to high ultrafiltration rates during closed batch hemodialysis.

P. Jungers, J. Zingraff, N. Man, 1978, Artificial organs.

HLA-A1, B8-phenotype association and HBs antigenemia evolution in 440 hemodialyzed patients.

C. Degott, P. Jungers, J. Zingraff, 1977, Digestion.

Treatment of multiple myeloma with renal involvement.

P. Jungers, P. Landais, V. Guérin, 1992, Advances in nephrology from the Necker Hospital.

LUPUS ANTICOAGULANT AND THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS

P. Jungers, J. Bach, M. Dautzenberg, 1984, The Lancet.

[Hormonal study of gonadal function in chronic hemodialysis patients (author's transl) (proceedings)].

P. Jungers, J. Zingraff, M. Roger, 1976, Annales d'Endocrinologie.

Pregnancy during dialysis: case report and management guidelines.

P. Jungers, J. Carlson, I. Giatras, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Chronic kidney disease and pregnancy.

P. Jungers, D. Droz, G. Albouze, 1986, Advances in nephrology from the Necker Hospital.

Bilateral fracture of the femoral neck complicating uremic bone disease prior to chronic hemodialysis.

P. Jungers, J. Zingraff, N. Man, 1974, Clinical nephrology.

[Arterial hypertension and mortality due to cardiovascular complications in patients on chronic hemodialysis].

P. Jungers, J. Zingraff, T. Drueke, 1978, Archives des maladies du coeur et des vaisseaux.

[Arteriovenous fistulas of the renal pedicle following nephrectomy].

P. Jungers, M. Lacombe, O. Nussaume, 1973, Annales de chirurgie thoracique et cardio-vasculaire.

Renal granulomatous sarcoidosis: report of six cases.

P. Jungers, J. Grünfeld, T. Hannedouche, 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[Dysregulation of the immune system in chronic uremic and hemodialysed patients].

P. Jungers, L. Chatenoud, B. Descamps-Latscha, 1995, Presse medicale.

[The correction of arterial hypertension by renal transplantation in man].

P. Jungers, J. Funck-Brentano, J. Crosnier, 1965, Pathologie et biologie.

Neuropathy and "middle" molecule toxins.

P. Jungers, N. Man, T. Drueke, 1975, Kidney international. Supplement.

[Anatomoclinical study of extramembraneous glomerulonephritis].

P. Jungers, N. Hinglais, H. de Montera, 1969, Journal d'urologie et de nephrologie.

The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites

P. Jungers, J. Aldigier, M. Rouan, 1994, European Journal of Clinical Pharmacology.

The effect of immunosuppressive agents on T-cell subsets, as evaluated by use of monoclonal anti-T-cell antibodies.

P. Jungers, L. Chatenoud, J. Bach, 1981, Transplantation proceedings.

[Drinking water and urinary stones. Which drinking water and which modalities of diuresis?].

M. Daudon, P. Jungers, P. Hartemann, 2002, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients.

G. London, P. Jungers, B. Descamps-Latscha, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus.

M. Dougados, P. Jungers, J. Bach, 1982, Arthritis and rheumatism.

Membranous glomerulonephritis and pregnancy.

P. Jungers, M. Henry-Amar, D. Forget, 1988, Clinical Nephrology.

[Hormonal modulation in disseminated lupus erythematosus: the preliminary results with danazol and cyproterone acetate].

M. Dougados, P. Jungers, J. Bach, 1986, Annales de medecine interne.

Increased nitrogen removal from the intestinal tract of uraemic patients.

P. Jungers, J. Zingraff, N. Man, 1973, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Clinical use of oxystarch.

P. Jungers, J. Zingraff, N. Man, 1976, Kidney international. Supplement.

Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.

P. Jungers, G. Choukroun, J. Grünfeld, 1995, Journal of the American Society of Nephrology : JASN.

Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who are non-responders to hepatitis B vaccine

H. Salomón, P. Jungers, A. Couroucé, 1994, The Lancet.

Immunogenicity of the recombinant GenHevac B Pasteur vaccine against hepatitis B in chronic uremic patients.

P. Jungers, J. Excler, P. Chauveau, 1994, The Journal of infectious diseases.

Trace elements modify the activity of sodium transporting systems in erythrocyte membrane in patients with essential hypertension – preliminary study

M. Daudon, P. Jungers, B. Lacour, 2005 .

[Evaluation of the lithogenic risk in renal lithiasis. Value of urine density measurement].

M. Daudon, P. Jungers, B. Lacour, 1995, Presse medicale.

Effects of high dialysate calcium concentration on bone remodelling, serum biochemistry, and parathyroid hormone in patients with renal osteodystrophy.

P. Jungers, T. Drüeke, N. Man, 1977, Kidney international.

Evaluation of plasma neurotoxin concentration in uraemic polyneuropathic patients.

J. Boudet, P. Jungers, J. Zingraff, 1978, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Response of Patients with Medullary Sponge Kidney and Calcium Nephrolithisis to an Acute Acid Load

P. Houillier, M. Daudon, P. Jungers, 1989 .

Influence of pregnancy on the course of primary chronic glomerulonephritis

P. Jungers, B. Descamps-Latscha, I. Giatras, 1995, The Lancet.

Influence of renal insufficiency on the pharmacokinetics and pharmacodynamics of terazosin.

P. Jungers, P. Chauveau, N. Pertuiset, 1986, The American journal of medicine.

One year follow-up of short dialysis with a membrane highly permeable to middle molecules.

P. Jungers, J. Zingraff, N. Man, 1973, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Nonprogressive Kidney Dysfunction and Outcomes in Older Adults with Chronic Kidney Disease

C. Elie, M. Daudon, P. Jungers, 2009, Journal of the American Geriatrics Society.

RESPONSES TO HEPATITIS B VACCINE

P. Jungers, A. Laplanche, E. Benhamou, 1982, The Lancet.

Steady-state levels of pefloxacin and its metabolites in patients with severe renal impairment

P. Jungers, T. Hannedouche, G. Montay, 2004, European Journal of Clinical Pharmacology.

Amino acids and keto acids in the treatment of chronic renal failure.

P. Jungers, P. Chauveau, 1988, Blood purification.

Reflux nephropathy and pregnancy.

P. Houillier, P. Jungers, D. Forget, 1987, Bailliere's clinical obstetrics and gynaecology.

Lupus Nephropathy and Pregnancy: Report of 104 Cases in 36 Patients

M. Dougados, P. Jungers, J. Bach, 1983 .

[Hormonal contraception and lupus].

M. Dougados, P. Jungers, F. Lioté, 1990, Annales de medecine interne.

PIRIDOXILATE-ASSOCIATED CALCIUM OXALATE URINARY CALCULI: A NEW METABOLIC DRUG-INDUCED NEPHROLITHIASIS

M. Daudon, P. Jungers, R. Reveillaud, 1985, The Lancet.

[Anuric complications after perfusion urography in patients with renal failure, myeloma excepted].

P. Jungers, D. Kleinknecht, J. Michel, 1972, La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris.

[Neoplasmic acute hypercalcemia with kidney failure. Possibilities and limitations of treatment by extrarenal purification].

P. Jungers, J. Chanard, D. Kleinknecht, 1971, La Presse medicale.

HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?

P. Jungers, A. Laplanche, E. Benhamou, 1984, The Lancet.